Navigation Links
Cell Therapeutics, Inc.'s (CTI) Presentation at BIO Investor Forum to be Webcast
Date:10/29/2009

SEATTLE, Oct. 29 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) management will present at the 8th Annual Biotechnology Industry Organization (BIO) Investor Forum on Thursday, October 29 at 10:00 a.m. Pacific Time.

The conference is being held October 28-29, 2009, at the Palace Hotel in San Francisco. The presentation will be webcast live with slides and available for replay afterwards. The webcast can be accessed at www.celltherapeutics.com. 

                                BIO Investor Forum
                   CTI Presentation: Thursday, October 29, 2009
         10:00 a.m. Pacific /1:00 p.m. Eastern/7:00 p.m. Central European
              Audio webcast with slides at www.celltherapeutics.com

    Media Contact:
    Dan Eramian
    T: 206.272.4343
    C: 206.854.1200
    F: 206.272.4434
    E: deramian@ctiseattle.com
    www.celltherapeutics.com/press_room

    Investors Contact:
    Ed Bell
    T: 206.272.4345
    Lindsey Jesch Logan
    T: 206.272.4347
    F: 206.272.4434
    E: invest@ctiseattle.com
    www.celltherapeutics.com/investors

SOURCE Cell Therapeutics, Inc.


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1

Related biology technology :

1. Oxygen Biotherapeutics, Inc. Expands Board of Directors
2. The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
3. Intarcia Therapeutics, Inc. Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabetes Conference
4. New Oxygen Biotherapeutics, Inc. Investor Presentation Available on Company Website
5. Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The Report
6. Sorrento Therapeutics, Inc. and QuikByte Software, Inc. Complete Merger
7. Intarcia Therapeutics, Inc. Commences Enrollment of ITCA 650 Phase 2 Study in Type 2 Diabetes
8. Cell Therapeutics, Inc. (CTI) Advances Pixantrone Filing Process in Europe; Submits Pediatric Investigation Plan (PIP)
9. Cell Therapeutics, Inc. (CTI) to Present at BioCenturys NewsMakers in the Biotech Industry Conference
10. Oxygen Biotherapeutics, Inc. Seeks Shareholder Approval for Reverse Stock Split
11. Cell Therapeutics, Inc. (CTI) to Present at Rodman & Renshaw Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... and politicians, and has been recounted everywhere from tourist ... forces used chemical weapons on Iraqis just after World ... been fully squared with the historical record, says R. ... Douglas,s research, forthcoming in the December issue of The ... ever occurred. , Allegations of chemical bombings by ...
(Date:12/16/2009)... a simple, cheap, accurate test to find undetected landmines. ... a custom-made bacteria that glows green when it comes ... The bacteria can be mixed into a colourless solution ... patches to indicate the presence of landmines. , ... produce, could be delivered from the air onto areas ...
(Date:12/16/2009)... East Anglia (UEA) could contribute to the development of ... clean electricity. , Published today by the leading scientific ... (PNAS), the researchers have demonstrated for the first ... ,breathing rocks,. , The findings could be applied to ... as fuel cells, or ,bio-batteries, powered by animal or ...
(Date:12/16/2009)... FDA researchers have found that certain cardiac pacemakers ... a magnetic resonance imaging (MRI) scan due to ... from the pacemaker. This inadequate stimulation is ... scan, according to research published in BioMed Central,s ... , MRI is an imaging technique that uses ...
Breaking Biology Technology:Despite claims, UK did not gas Iraqis in the 1920s, new research finds 2Despite claims, UK did not gas Iraqis in the 1920s, new research finds 3Despite claims, UK did not gas Iraqis in the 1920s, new research finds 4'Rock-breathing' bacteria could generate electricity and clean up oil spills 2FDA researchers identify new MRI safety risk for patients with pacemakers 2
... Multiple presentations included Resverlogix data, TSX Exchange ... Resverlogix Corp.,("Resverlogix" or the "Company") (TSX:RVX) is pleased ... data pertaining to its lead compound,RVX-208, at the ... presentation titled "RVX-208 a novel small molecule that ...
... BioIT Alliance Dedicated to Advancing Personalized Medicine by Improving ... ... Waters Corporation,(NYSE: WAT ) today announced that it ... involving more than 80,pharmaceutical, biotech, laboratory instrument and software companies,working ...
... Sept. 2 StopAfib.org, at, http://www.StopAfib.org, announces that ... life-threatening irregular heartbeat,commonly called afib or AF., Once ... congestive heart failure or stroke. Every five minutes, someone ... is our #3 killer and the #1 cause of,permanent ...
Other Biology Technology:ApoA-I Data Presented at European Society of Cardiology Congress 2Waters Brings Advanced Laboratory Data Management to Microsoft's BioIT Alliance 2Waters Brings Advanced Laboratory Data Management to Microsoft's BioIT Alliance 3Atrial Fibrillation Month - StopAfib.org Announces September Focus on Life-Threatening Irregular Heartbeat 2
(Date:12/15/2009)... -- The 2009 Frost & Sullivan European ... to Sagem Securite (Safran Group) for its ... recognises the company,s expertise in advanced biometric ... novel, value-added products to end users. ... "Sagem Securite has been involved in delivering ...
(Date:12/15/2009)... the British Society for Research on Ageing (BSRA) to ... for an initial period of three years. ... Biogerontology editorial board and will acquire articles for ... society and provide society members with free electronic access ... Biogerontology offers a platform for research which ...
(Date:12/15/2009)... and Ghent University in Flanders, Belgium have found an ... major cause of death in intensive care units. By ... mice with septic shock, researchers Anje Cauwels and Peter ... damage, while their chances of survival increased significantly. That,s ... that nitric oxide is responsible for the potentially lethal ...
Breaking Biology News(10 mins):Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 2Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 3Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 4Septic shock: Nitric oxide beneficial after all 2Washington State Nurses Association Seeks Injunction in Federal Court to Block Mandatory Vaccination Policy by MultiCare Health System 58699 1Washington State Nurses Association Seeks Injunction in Federal Court to Block Mandatory Vaccination Policy by MultiCare Health System 58699 24 000 Registered for Redlands 2nd Annual Believe and Walk for the Cure 58695 14 000 Registered for Redlands 2nd Annual Believe and Walk for the Cure 58695 24 000 Registered for Redlands 2nd Annual Believe and Walk for the Cure 58695 3Enerkem Announces Unique Community Energy Project 14318 1Enerkem Announces Unique Community Energy Project 14318 2
... new paper in the February 15th issue of Genes ... that occur in sperm while they reside in the ... molecular genetics of successful fertilization. , It had been ... Dr. Yael Gur and Haim Breitbart (Bar-Ilan University, Israel) ...
... cardiovascular events -- a combined endpoint including stroke, heart ... both men and women, according to a new meta-analysis ... Medical Center cardiologist. , However, the researchers found, the ... sexes. For men, aspirin lowered the risk of a ...
... puts on its biggest growth spurt during the dry season, ... "Most of the vegetation around the world follows a general ... rainy season and then during the dry season, leaves fall ... plant growth," said lead researcher Alfredo R. Huete of The ...
Other Biology News:Aspirin reduces cardiovascular risks in men and women -- but differently 2Aspirin reduces cardiovascular risks in men and women -- but differently 3Amazon rainforest greens up in the dry season 2Amazon rainforest greens up in the dry season 3
SAIVI Alexa Fluor 680 injectable contrast agent *bovine serum albumin*...
Component of GELase™ Agarose Gel-Digesting Preparation. 1 ml of 50X Buffer is sufficient for replacing the buffer in at least 5 g of gel....
RABBIT ANTI QUINOLINIC ACID...
RAT ANTI MOUSE METALLOPHILIC MACROPHAGES...
Biology Products: